Sept 26, 2022
Insulin Sensitizers May Be Making a Comeback
The number of FDA-approved diabetes drugs to lower blood sugar is growing rapidly, with varying mechanisms of action. Among the choices, the 2 classes of antidiabetic drugs that are insulin sensitizers—the biguanides and thiazolidinediones (TZDs)—are unique.